2020
DOI: 10.1080/00365521.2020.1847318
|View full text |Cite
|
Sign up to set email alerts
|

Graft assessment for acute rejection after intestinal transplantation: current status and future perspective

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 71 publications
0
4
0
Order By: Relevance
“…In the context of intestinal transplantation, graft assessment remains reliant on serial mucosal biopsies [28]. Temporary ostomies are often created to facilitate biopsy collection, avoiding complications associated with colonoscopies and minimizing patient discomfort.…”
Section: Ostomy New Variationsmentioning
confidence: 99%
“…In the context of intestinal transplantation, graft assessment remains reliant on serial mucosal biopsies [28]. Temporary ostomies are often created to facilitate biopsy collection, avoiding complications associated with colonoscopies and minimizing patient discomfort.…”
Section: Ostomy New Variationsmentioning
confidence: 99%
“…However, the discontinuation of scheduled biopsies after ileostomy closure poses challenges in the early detection of acute rejection [9,10]. Therefore, the identification of novel molecular biomarkers that can be non-invasively detected with high accuracy has been a crucial goal in aiding the clinical detection of rejection in intestinal transplantation [11][12][13].…”
Section: Introductionmentioning
confidence: 99%
“… 2 Unlike other solid organ transplant models, there are no universally accepted biochemical markers with which to diagnose, monitor, or even predict IT graft failure. 3 The current gold standard for post-IT evaluation involves constant and coordinated clinical, laboratory, and histopathologic testing. However, there is considerable variability over the approach and frequency of routine biopsy of acute cellular rejection (ACR) across approved IT programs in the United States.…”
Section: Introductionmentioning
confidence: 99%